Maes, Michael

Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events

Maes, M., Lin, A.-H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., & Bosmans, E. (1999) · Biological Psychiatry

Posttraumatic Stress Disorder ResearchStress Responses and Cortisol

Cited by 387

Effects of antidepressants on the production of cytokines

Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 370

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

Maes, M. H. J., Bosmans, E., Meltzer, H. Y., Scharpé, S., & Suy, E. (1993) · American Journal of Psychiatry

Stress Responses and CortisolTryptophan and brain disorders

Cited by 364

Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio

Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 343

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 329

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 325

The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder

Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 306

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response

Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 302

The monocyte-T-lymphocyte hypothesis of major depression

Maes, M., Smith, R., & Simon, S. (1995) · Psychoneuroendocrinology

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 299

Interplay between the gut-brain axis, obesity and cognitive function

Agustí, A., García-Pardo, M. P., López-Almela, I., Campillo, I., Maes, M., Romaní-Pérez, M., & Sanz, Y. (2018) · Frontiers in Neuroscience

Gut microbiota and healthRegulation of Appetite and Obesity

Cited by 294

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

Slyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 278

Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining

Maes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, C., De Jonckheere, C., Minner, B., & Raus, J. (1992) · Psychological Medicine

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 275

Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness

Maes, M., Vandoolaeghe, E., Neels, H., Demedts, P., Wauters, A., Meltzer, H. Y., Altamura, C., & Desnyder, R. (1997) · Biological Psychiatry

Trace Elements in HealthTreatment of Major Depression

Cited by 272

Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production

Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., & Raus, J. (1991) · Acta Psychiatrica Scandinavica

Stress Responses and CortisolTryptophan and brain disorders

Cited by 268

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine

Treatment of Major DepressionTryptophan and brain disorders

Cited by 252

Α Review on the Acute Phase Response in Major Depression

Maes, M. (1993) · Reviews in the Neurosciences

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 239

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 232

Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers.

Maes, M., Mommen, K., Hendrickx, D., Peeters, D., D’Hondt, P., Ranjan, R., De Meyer, F., & Scharpe, S. (1997) · Clinical Endocrinology

Clinical Laboratory Practices and Quality ControlThyroid Disorders and Treatments

Cited by 231

Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study

Lopresti, A. L., Maes, M., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Journal of Affective Disorders

Curcumin's Biomedical ApplicationsTreatment of Major Depression

Cited by 216

Increased 24‐hour urinary cortisol excretion in patients with post‐traumatic stress disorder and patients with major depression, but not h patients with fibromyalgia

Maes, M., Lin, A., Bonacccorso, S., Van Hunsel, F., GASTEL, A. V., Delmeire, L., Biondi, M., Bosmans, E., Kenis, G., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica

Stress Responses and CortisolPosttraumatic Stress Disorder Research

Cited by 204

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders

Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 204

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J. (2001) · Psychoneuroendocrinology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 201

Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut–intestinal permeability

Maes, M., Mihaylova, I., & Leunis, J.-C. (2007) · Journal of Affective Disorders

Fibromyalgia and Chronic Fatigue Syndrome ResearchGastrointestinal motility and disorders

Cited by 197

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

Altamura, C., Maes, M., Dai, J., & Meltzer, H. Y. (1995) · European Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 193